Diabetes

Model demonstrates cost-effectiveness of canagliflozin in type 2 diabetes

The researchers report in Diabetes Therapy that the clinical benefits associated with canagliflozin use, such as the preservation of estimated …

Read more at www.medwirenews.com

Show More

Related Articles

Back to top button